Studies of Empagliflozin and Its Cardiovascular, Renal and Metabolic Effects

NCT03485092 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure
Diabetes Mellitus

Interventions

DRUG: Empagliflozin 10 MG
DRUG: Placebo Oral Tablet

Sponsor

NHS Greater Glasgow and Clyde

Collaborators

[object Object]